Literature DB >> 21325622

Damage-associated molecular pattern S100A9 increases bactericidal activity of human neutrophils by enhancing phagocytosis.

Jean-Christophe Simard1, Marie-Michelle Simon, Philippe A Tessier, Denis Girard.   

Abstract

The damage-associated molecular-pattern S100A9 is found at inflammatory sites in infections and various autoimmune diseases. It is released at very high concentrations in the extracellular milieu by activated neutrophils and monocytes in response to various agents. This proinflammatory protein is found in infected mucosae and tissue abscesses where it acts notably as a potent neutrophil activator. In this study, we examined the role of S100A9 in the control of infections. S100A9 was found to increase human neutrophil bactericidal activity toward Escherichia coli. Although S100A9 induced the accumulation of reactive oxygen species over time through the activation of NADPH oxidase, its antimicrobial activity was mediated mainly by enhancing the efficiency of neutrophil phagocytosis. Interestingly, S100A9 did not act by increasing cell surface expression of CD16, CD32, or CD64 in neutrophils, indicating that its biological effect in FcR-mediated phagocytosis is independent of upregulation of FcγR levels. However, S100A9-induced phagocytic activity required the phosphorylation of Erk1/2, Akt, and Syk. Taken together, our results demonstrate that S100A9 stimulates neutrophil microbicidal activity by promoting phagocytosis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21325622     DOI: 10.4049/jimmunol.1002956

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  39 in total

Review 1.  New insights into the regulation of neutrophil NADPH oxidase activity in the phagosome: a focus on the role of lipid and Ca(2+) signaling.

Authors:  Sabrina Bréchard; Sébastien Plançon; Eric J Tschirhart
Journal:  Antioxid Redox Signal       Date:  2012-09-18       Impact factor: 8.401

Review 2.  Calprotectin in rheumatic diseases.

Authors:  Francesca Ometto; Lara Friso; Davide Astorri; Costantino Botsios; Bernd Raffeiner; Leonardo Punzi; Andrea Doria
Journal:  Exp Biol Med (Maywood)       Date:  2016-01-01

3.  MRP8/14 enhances corneal susceptibility to Pseudomonas aeruginosa Infection by amplifying inflammatory responses.

Authors:  Qiuchan Deng; Mingxia Sun; Kun Yang; Min Zhu; Kang Chen; Jin Yuan; Minhao Wu; Xi Huang
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-02-01       Impact factor: 4.799

4.  Mechanism involved in interleukin-21-induced phagocytosis in human monocytes and macrophages.

Authors:  F Vallières; D Girard
Journal:  Clin Exp Immunol       Date:  2016-11-22       Impact factor: 4.330

5.  Regulation of TLR3 Activation by S100A9.

Authors:  Su-Yu Tsai; Jesus A Segovia; Te-Hung Chang; Niraj K Shil; Swechha M Pokharel; T R Kannan; Joel B Baseman; Joan Defrêne; Nathalie Pagé; Annabelle Cesaro; Philippe A Tessier; Santanu Bose
Journal:  J Immunol       Date:  2015-09-18       Impact factor: 5.422

Review 6.  Novel insights into the role of S100A8/A9 in skin biology.

Authors:  Claus Kerkhoff; Andreas Voss; Thomas E Scholzen; Michelle M Averill; Kurt S Zänker; Karin E Bornfeldt
Journal:  Exp Dermatol       Date:  2012-08-09       Impact factor: 3.960

Review 7.  Functions of S100 proteins.

Authors:  R Donato; B R Cannon; G Sorci; F Riuzzi; K Hsu; D J Weber; C L Geczy
Journal:  Curr Mol Med       Date:  2013-01       Impact factor: 2.222

Review 8.  Current siRNA targets in atherosclerosis and aortic aneurysm.

Authors:  Leena Pradhan-Nabzdyk; Chenyu Huang; Frank W LoGerfo; Christoph S Nabzdyk
Journal:  Discov Med       Date:  2014-05       Impact factor: 2.970

9.  Evaluation of the in vitro and in vivo proinflammatory activities of gold (+) and gold (-) nanoparticles.

Authors:  Isabelle Durocher; Claudie Noël; Valérie Lavastre; Denis Girard
Journal:  Inflamm Res       Date:  2017-07-04       Impact factor: 4.575

10.  Augmentation of epithelial resistance to invading bacteria by using mRNA transfections.

Authors:  Xianqiong Zou; Brent S Sorenson; Karen F Ross; Mark C Herzberg
Journal:  Infect Immun       Date:  2013-08-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.